The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix
Aim: Villoglandular adenocarcinoma (VGA) of the uterine cervix is a variant of endocervical adenocarcinoma. However, the clinicopathologic and immunohistochemical features of VGA are still unclear. The aim of this study was to investigate the clinicopathologic and immunohistochemical features of VGA...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Indian Journal of Pathology and Microbiology |
Subjects: | |
Online Access: | http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2018;volume=61;issue=4;spage=549;epage=552;aulast=Huang |
id |
doaj-4ccbbd70741b41eab1aa646bce6a5785 |
---|---|
record_format |
Article |
spelling |
doaj-4ccbbd70741b41eab1aa646bce6a57852020-11-24T21:50:06ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49292018-01-0161454955210.4103/IJPM.IJPM_144_18The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervixZhuo-Ya HuangSisi ZhangYao-Zhong ZhangJian-Hong AnJiao LuoPeng-Juan LiaoQing ChenHong ShenAim: Villoglandular adenocarcinoma (VGA) of the uterine cervix is a variant of endocervical adenocarcinoma. However, the clinicopathologic and immunohistochemical features of VGA are still unclear. The aim of this study was to investigate the clinicopathologic and immunohistochemical features of VGA. Materials and Methods: A total of 20 VGA patients were identified among 852 patients diagnosed with cervical cancer and enrolled in this study. The immunohistochemical levels of Ki-67, P53, P16, progesterone receptor (PR), carcinoembryonic antigen (CEA), vimentin (Vim), and estrogen receptor (ER) were measured by immunohistochemistry. Results: VGA was prevalent in younger women and presented favorable prognosis. Ki-67, P16, and CEA were highly expressed in VGA tissues, while PR expression was hardly to be detected. The positive rates of Ki-67, CEA, and P16 were 90.0%, 90.0%, and 85.0%, respectively, which were significantly higher compared with PR (5.0%, P < 0.001). In addition, the positive rates of P53, Vim, and ER in VGA tissues were 55.0%, 50.0%, and 40.0%, respectively. However, the expression levels of Ki-67, P53, P16, PR, CEA, Vim, and ER were not significantly associated with clinical features (P > 0.05). Conclusion: These data indicate that VGA is a rare cervical adenocarcinoma, which is prevalent in younger women, and presents favorable prognosis. Detection of Ki-67, P53, P16, PR, CEA, Vim, and ER would be beneficial for the diagnosis of VGA.http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2018;volume=61;issue=4;spage=549;epage=552;aulast=HuangClinical stageclinicopathologic featurehuman papillomavirus infectionsoutcomevilloglandular adenocarcinoma |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zhuo-Ya Huang Sisi Zhang Yao-Zhong Zhang Jian-Hong An Jiao Luo Peng-Juan Liao Qing Chen Hong Shen |
spellingShingle |
Zhuo-Ya Huang Sisi Zhang Yao-Zhong Zhang Jian-Hong An Jiao Luo Peng-Juan Liao Qing Chen Hong Shen The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix Indian Journal of Pathology and Microbiology Clinical stage clinicopathologic feature human papillomavirus infections outcome villoglandular adenocarcinoma |
author_facet |
Zhuo-Ya Huang Sisi Zhang Yao-Zhong Zhang Jian-Hong An Jiao Luo Peng-Juan Liao Qing Chen Hong Shen |
author_sort |
Zhuo-Ya Huang |
title |
The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix |
title_short |
The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix |
title_full |
The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix |
title_fullStr |
The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix |
title_full_unstemmed |
The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix |
title_sort |
clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix |
publisher |
Wolters Kluwer Medknow Publications |
series |
Indian Journal of Pathology and Microbiology |
issn |
0377-4929 |
publishDate |
2018-01-01 |
description |
Aim: Villoglandular adenocarcinoma (VGA) of the uterine cervix is a variant of endocervical adenocarcinoma. However, the clinicopathologic and immunohistochemical features of VGA are still unclear. The aim of this study was to investigate the clinicopathologic and immunohistochemical features of VGA. Materials and Methods: A total of 20 VGA patients were identified among 852 patients diagnosed with cervical cancer and enrolled in this study. The immunohistochemical levels of Ki-67, P53, P16, progesterone receptor (PR), carcinoembryonic antigen (CEA), vimentin (Vim), and estrogen receptor (ER) were measured by immunohistochemistry. Results: VGA was prevalent in younger women and presented favorable prognosis. Ki-67, P16, and CEA were highly expressed in VGA tissues, while PR expression was hardly to be detected. The positive rates of Ki-67, CEA, and P16 were 90.0%, 90.0%, and 85.0%, respectively, which were significantly higher compared with PR (5.0%, P < 0.001). In addition, the positive rates of P53, Vim, and ER in VGA tissues were 55.0%, 50.0%, and 40.0%, respectively. However, the expression levels of Ki-67, P53, P16, PR, CEA, Vim, and ER were not significantly associated with clinical features (P > 0.05). Conclusion: These data indicate that VGA is a rare cervical adenocarcinoma, which is prevalent in younger women, and presents favorable prognosis. Detection of Ki-67, P53, P16, PR, CEA, Vim, and ER would be beneficial for the diagnosis of VGA. |
topic |
Clinical stage clinicopathologic feature human papillomavirus infections outcome villoglandular adenocarcinoma |
url |
http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2018;volume=61;issue=4;spage=549;epage=552;aulast=Huang |
work_keys_str_mv |
AT zhuoyahuang theclinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix AT sisizhang theclinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix AT yaozhongzhang theclinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix AT jianhongan theclinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix AT jiaoluo theclinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix AT pengjuanliao theclinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix AT qingchen theclinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix AT hongshen theclinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix AT zhuoyahuang clinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix AT sisizhang clinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix AT yaozhongzhang clinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix AT jianhongan clinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix AT jiaoluo clinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix AT pengjuanliao clinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix AT qingchen clinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix AT hongshen clinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix |
_version_ |
1725885256488189952 |